First-generation antihistamines confirmed as problematic in adults 65+
Key Questions
Why are first-generation antihistamines like Benadryl problematic for adults over 65?
First-generation antihistamines such as diphenhydramine (Benadryl), doxylamine, and chlorpheniramine carry risks including dementia, heart issues, COPD exacerbation, anticholinergic effects, and physical decline, as reinforced by Beers criteria. These risks are confirmed in new flags for adults 65 and older.
What specific first-generation antihistamines have new risk flags?
New flags apply to DPH (Benadryl/Theraflu), doxylamine/chlorpheniramine (Robitussin/Dallergy Nighttime), and brompheniramine/chlorpheniramine combinations. These add to prior known risks in older adults.
What are the main risks associated with these antihistamines in seniors?
Risks include anticholinergic effects leading to physical decline, dementia, heart problems, and COPD worsening. Studies and analyses confirm these impacts on physical function and overall health.
What safer alternatives exist to first-generation antihistamines?
Second-generation antihistamines and saline nasal sprays are safer options for allergy and cold relief in adults 65+. They avoid the anticholinergic and sedative risks of first-generation drugs.
How do drug interactions factor into the risks of these antihistamines?
Reports show multiple interactions, such as Benadryl with Emergen-C or clidinium with Robitussin Nighttime, increasing potential warnings. Experts warn these common meds may harm more than help after age 60.
New flags on DPH (Benadryl/Theraflu), doxylamine/chlorphen (Robitussin/Dallergy Nighttime), bromphen/chlorphen add to prior risks (dementia/heart/COPD anticholin/physical decline); Beers reinforced. Second-gen/saline safer.